Real-world-data Enabled Assessment for heaLth regulatory decision-Makingcore
REALM · Horizon Europe grant · 2023-01-01–2026-12-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-HLTH-2022-TOOL-11 · scheme HORIZON-RIA · topic HORIZON-HLTH-2022-TOOL-11-02. CORDIS record →
Objective
The overall aim of the REALM project is to create a collaborative framework for regulatory authorities, application developers, healthcare professionals and policy officers to co-create and evaluate software for medical and healthcare use. We propose to create an inclusive platform leading to a transparent ecosystem for evaluation and certification of software in healthcare where both the developers and the regulatory (and Health Technology Assessment) bodies have access to a standardized set of technology stack and data. This will be achieved by first mapping and analyzing regulations, legislative efforts and guidelines from EU, national bodies and around the world on software in healthcare practice. These will guide the roadmap towards building an inclusive, fair and multi-stakeholder ecosystem. The scaffold for an integrated architecture will be developed in collaboration with DARWIN, based on standardized data models and optimized data driven methodologies for the effective use of real-world data (RWD) in healthcare regulatory practice. The architecture will consist of four components: two technological infrastructures, a living lab and a post-marketing surveillance module. i) a federated cloud-based data resources catalog will be established, to bring together currently available RWD data and synthetic data to facilitate the data needs of the platform. ii) Regulatory Toolbox will be established to bring together standardized tools to train, test, evaluate and monitor medical/healthcare software. iii) Living lab environment for piloting medical/healthcare software technology assessment taking into account human-software interactions as part of the system. iv) Post-marketing surveillance with RWD for ensuring quality standards of the certified software in practice. Finally, building on the proposed architecture, five real Medical Device Software (MDSW) projects are going to be implemented across 3 countries (Netherlands, Belgium and Greece).
Beneficiaries (16)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| UNIVERSITEIT MAASTRICHT | NL | coordinator | €1,666,875 | |
| VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V. | BE | participant | €1,212,500 | |
| EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS | EL | participant | €672,500 | Yes |
| EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH | DE | participant | €598,375 | Yes |
| YAGHMA B.V. | NL | participant | €495,375 | Yes |
| METAMIND INNOVATIONS IKE | EL | participant | €440,750 | Yes |
| TRAQBEAT TECHNOLOGIES IDIOTIKI KEFA | EL | participant | €430,000 | Yes |
| COMUNICARE SOLUTIONS | BE | participant | €364,375 | Yes |
| UNIVERSITE DE LIEGE | BE | participant | €320,500 | |
| VIRTUAL PHYSIOLOGICAL HUMAN INSTITUTE FOR INTEGRATIVE BIOMEDICAL RESEARCH VZW | BE | participant | €148,750 | |
| UCZELNIA LAZARSKIEGO | PL | participant | €136,625 | |
| UNIWERSYTET WARSZAWSKI | PL | participant | €135,125 | |
| UNIVERSITEIT ANTWERPEN | BE | participant | €37,900 | |
| RESEARCH AND INNOVATION SERVICES DOO ZA USLUGE | HR | thirdParty | €0 | Yes |
| UNIVERSITY OF BRISTOL | UK | associatedPartner | — | |
| THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD | UK | associatedPartner | — |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.